Growth Metrics

Crescent Biopharma (CBIO) Cash from Investing Activities Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -114.28%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -674.01%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -122.45%
10 Crescent Biopharma 569.36 Mn 380.20 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -5,427.04%
Jun 30, 2024 75.94%
Mar 31, 2024 -238.60%
Dec 31, 2023 -80,000.00%
Sep 30, 2023 -216.79%
Jun 30, 2023 74.43%
Mar 31, 2023 94.58%
Dec 31, 2022 99.96%
Sep 30, 2022 42.71%
Jun 30, 2022 -707.25%
Mar 31, 2022 -1,224.22%
Dec 31, 2021 93.59%
Sep 30, 2021 72.59%
Jun 30, 2021 20.07%
Mar 31, 2021 62.39%
Dec 31, 2020 -208.93%
Sep 30, 2020 13.43%
Jun 30, 2020 91.46%
Mar 31, 2020 79.42%
Dec 31, 2019 78.32%
Sep 30, 2019 31.23%
Jun 30, 2019 -193.94%
Mar 31, 2019 -137.92%
Dec 31, 2018 -66.45%
Sep 30, 2018 18.74%
Jun 30, 2018 84.51%
Mar 31, 2018 73.61%
Dec 31, 2017 92.19%
Sep 30, 2017 85.50%
Jun 30, 2017 -614.55%
Mar 31, 2017 -264.61%
Dec 31, 2016 -13,490.55%
Sep 30, 2016 -285.99%
Jun 30, 2016 88.77%
Mar 31, 2016 -638.35%
Dec 31, 2015 78.29%
Sep 30, 2015 42.75%
Jun 30, 2015 -150.11%
Mar 31, 2015 83.20%
Dec 31, 2014 -19.59%
Sep 30, 2014 -160.41%
Jun 30, 2014 -245.69%
Mar 31, 2014 -103.99%